TLK286, a novel glutathione analog prodrug, is synergistic with carboplatin and paclitaxel as a triplet in human cancer cells
Jian‐Dong Jiang(Ningbo University), James F. Holland(Mayo Clinic), Yan Lin Wang, Premkumar Reddy(Onconova Therapeutics (United States)), Yan Li(The University of Texas Southwestern Medical Center)
Cancer Research
May 1, 2005
Cited by 0
Related Papers
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Association of Depression With Viral Load, CD8 T Lymphocytes, and Natural Killer Cells in Women With HIV Infection
|American Journal of Psychiatry|2002|324
Global, regional, and national burden of thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021
|EClinicalMedicine|2024|278
Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
|Alzheimer s & Dementia|2020|256
Filtration Leukapheresis for Granulocyte Transfusion Therapy
|New England Journal of Medicine|1975|255